Pfizer’s Lipitor revenue worldwide 2003-2019
During 2019, Pfizer’s Lipitor generated nearly two billion U.S. dollars of revenue. For around a decade cholesterol-lowering drug Lipitor was one of the company’s top blockbusters, with record-high revenues of approximately 13 billion U.S. dollars in 2006. In the year of patent loss – 2011 – Lipitor still generated roughly 10 billion dollars, before a heavy drop down to four billion dollars in 2012.
Pharmaceutical company Pfizer
Drug manufacturer Pfizer is headquartered in Midtown Manhattan, New York City. At this moment, it is the world’s leading pharmaceutical company based on pharmaceutical sales of prescribed and over-the-counter drugs. Today, the company is focused on human medicine, divided into two major segments – Innovative Health and Essential Health. However, until 2013 the company also had a notable animal health division which was spun-off and today is known as Zoetis.
Facts about Lipitor/atorvastatin
Lipitor was approved by the FDA (Food and Drug Administration) in 1996 for medical use. Since its patent protection expired in 2011, it is now also sold under its generic name atorvastatin. Today, atorvastatin is one of the most prescribed drugs in the United States. The drug is primarily used as prevention for people with a high risk for developing cardiovascular diseases and as a treatment for abnormal lipid levels (dyslipidemia). Generic versions of Lipitor lead to annual savings in drug spending of around 16 billion U.S. dollars.
Worldwide revenue of Pfizer’s Lipitor from 2003 to 2019 (in million U.S. dollars)
You need a Single Account for unlimited access.
- Full access to 1m statistics
- Incl. source references
- Available to download in PNG, PDF, XLS format
Access to this and all other statistics on 80,000 topics from
$468 / Year
$708 / Year
Show sources information Show publisher information Use Ask Statista Research Service
This statistic was assembled from several of Pfizer’s annual and financial reports.
Pharmaceutical Products & Market
Average price of drugs sold in pharmacies by therapeutic group in Spain 2019
Pharmaceutical Products & Market
Leading basic pharmaceutical products manufacturers in Spain in 2019
Pharmaceutical Products & Market
Leading pharmaceutical goods wholesalers in Spain in 2019
Average cost of medical prescriptions in pharmacies in Spain 2010-2019
Please create an employee account to be able to mark statistics as favorites. Then you can access your favorite statistics via the star in the header.
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set statistic alerts) please log in with your personal account. If you are an admin, please authenticate by logging in again.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
You can only download this statistic as a Premium user.
As a Premium user you get access to the detailed source references and background information about this statistic.
As a Premium user you get access to background information and details about the release of this statistic.
As soon as this statistic is updated, you will immediately be notified via e-mail.
. and make my research life easier.
You need at least a Single Account to use this feature.
Register in seconds and access exclusive features.
- Full access:
To this and over 1 million additional datasets - Save Time:
Downloads allow integration with your project - Valid data:
Access to all sources and background information
$39 per month*
(billed annually)
Get full access to all features within our Corporate Solutions.
- Immediate access to statistics, forecasts, reports and outlooks
- Usage and publication rights
- Download in various formats
You only have access to basic statistics.
This statistic is not included in your account.
